# Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-to-reduce-the-possible-risk-of-transmission-of-creutzfeldt-jakob-disease-and-variant-creutzfeldt-jakob-disease-by-blood-and-blood-components-guidance-for-industry/5a1bc246-799a-4448-ad8b-9f02df441719

> FDA guidance document: Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components:  Guidance for Industry. Issue date: May 23, 2022. Get complete insights and analysis.

---

## Details

- Title: Recommendations to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Components:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2022-05-23
- Last Changed: 2022-05-24
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2012-D-0307">FDA-2012-D-0307</a>

## Related Documents

- [Alternative Procedures for the Manufacture of Cold-Stored Platelets Intended for the Treatment of Active Bleeding when Conventional Platelets Are Not Available or Their Use Is Not Practical:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/alternative-procedures-for-the-manufacture-of-cold-stored-platelets-intended-for-the-treatment-of-active-bleeding-when-conventional-platelets-are-not-available-or-their-use-is-not-practical-guidance-for-industry/8cc4070d-c47d-4c02-9bda-48157ed8f034)
- [Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/recommendations-to-reduce-the-risk-of-transfusion-transmitted-malaria-guidance-for-industry/eb835388-a1e0-46db-8c55-61853bcee91b)
- [Biological Product Deviation Reporting for Blood and Plasma Establishments:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/biological-product-deviation-reporting-for-blood-and-plasma-establishments-guidance-for-industry/6c58653c-8367-4da8-9b28-4e92356ee9c7)